Emmaus Life Sciences (EMMA) Short Interest Ratio & Short Volume $0.02 0.00 (0.00%) As of 06/13/2025 01:08 PM Eastern Add Compare Share Share Short Interest Stock AnalysisChartEarningsHeadlinesSEC FilingsShort InterestBuy This Stock Emmaus Life Sciences Short Interest DataEmmaus Life Sciences (EMMA) has a short interest of 700 shares, representing 0.00% of the float (the number of shares available for trading by the public). This marks a 0.00% change in short interest from the previous month. The short interest ratio (days to cover) is 0.0, indicating that it would take 0.0 days of the average trading volume of 39,615 shares to cover all short positions.Current Short Interest700 sharesPrevious Short Interest700 sharesChange Vs. Previous MonthNo ChangeDollar Volume Sold Short$13.93Short Interest Ratio0.0 Days to CoverLast Record DateMay 31, 2025Outstanding Shares63,866,000 sharesShort Percent of Float0.00%Today's Trading Volume5,000 sharesAverage Trading Volume39,615 sharesToday's Volume Vs. Average13% Short Selling Emmaus Life Sciences? Sign up to receive the latest short interest report for Emmaus Life Sciences and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartEMMA Short Interest Over TimeEMMA Days to Cover Over TimeEMMA Percentage of Float Shorted Over Time Emmaus Life Sciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/31/2025700 shares $13.93 No Change0.0%0 $0.02 5/15/2025700 shares $8.40 -50.0%0.0%0 $0.01 4/30/20251,400 shares $23.10 -75.0%N/A0.4 $0.02 4/15/20255,600 shares $89.60 +16.7%0.0%0.7 $0.02 3/31/20254,800 shares $82.08 -25.0%0.0%0.2 $0.02 3/15/20256,400 shares $175.36 +30.6%0.0%0.1 $0.03 2/28/20254,900 shares $85.75 -51.5%0.0%0 $0.02 2/15/202510,100 shares $451.47 -53.5%0.0%0.1 $0.04 1/31/202521,700 shares $353.71 +47.6%N/A1.1 $0.02 1/15/202514,700 shares $205.80 +2,000.0%N/A0.6 $0.01 Get the Latest News and Ratings for EMMA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Emmaus Life Sciences and its competitors with MarketBeat's FREE daily newsletter. 12/31/2024700 shares $5.95 No ChangeN/A0 $0.01 12/15/2024700 shares $4.69 -22.2%N/A0 $0.01 11/30/2024900 shares $26.91 -10.0%N/A0 $0.03 11/15/20241,000 shares $36.50 +42.9%N/A0 $0.04 10/31/2024700 shares $24.50 No ChangeN/A0 $0.04 10/15/2024700 shares $24.50 No ChangeN/A0 $0.04 9/30/2024700 shares $20.86 No ChangeN/A0 $0.03 9/15/2024700 shares $26.25 No ChangeN/A0 $0.04 8/31/2024700 shares $0.21 No ChangeN/A1 $0.00 8/15/2024700 shares $2.10 No ChangeN/A0 $0.00 7/31/2024700 shares $1.75 No ChangeN/A0.1 $0.00 7/15/2024700 shares $49.91 No ChangeN/A0 $0.07 6/30/2024700 shares $70.70 No ChangeN/A0 $0.10 6/15/2024700 shares $64.01 No ChangeN/A0.1 $0.09 5/31/2024700 shares $64.40 No ChangeN/A0.1 $0.09 5/15/2024700 shares $72.10 No ChangeN/A0.3 $0.10 4/30/2024700 shares $70.00 No ChangeN/A0.1 $0.10 4/15/2024700 shares $73.50 -12.5%N/A0.9 $0.11 3/31/2024800 shares $84.00 -89.5%N/A0.1 $0.11 3/15/20247,600 shares $768.36 +33.3%N/A0.4 $0.10 2/29/20245,700 shares $676.02 +714.3%N/A0.1 $0.12 2/15/2024700 shares $67.27 -93.6%N/A0.1 $0.10 1/15/20244,100 shares $369.00 -6.8%N/A0.4 $0.09 12/31/20234,400 shares $440.33 +450.0%N/A0 $0.10 12/15/2023800 shares $88.00 -50.0%N/A0.1 $0.11 11/30/20231,600 shares $208.00 +128.6%N/A0 $0.13 11/15/2023700 shares $77.00 No ChangeN/A0 $0.11 10/31/2023700 shares $84.00 No ChangeN/A0 $0.12 10/15/2023700 shares $105.00 -22.2%N/A0 $0.15 9/30/2023900 shares $112.50 No ChangeN/A0.5 $0.13The End of Elon Musk…? (Ad)The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, and he's been proven right time and time again. And now, while the media focuses on Tesla's "demise," he's uncovered an AI breakthrough that's about to make Elon's doubters eat their words yet again. According to his research, if you listen to the media and miss out on Elon's newest breakthrough, it's going to cost you the fortune of a lifetime.Click here to see why the "End of Elon" crowd is about to be wrong again. 9/15/2023900 shares $117.00 +28.6%N/A0.1 $0.13 8/31/2023700 shares $105.88 -41.7%N/A0 $0.15 8/15/20231,200 shares $252.00 No ChangeN/A0.4 $0.21 7/31/20231,200 shares $264.00 +71.4%N/A0.2 $0.22 7/15/2023700 shares $168.35 -50.0%N/A0.1 $0.24 6/30/20231,400 shares $322.00 -68.9%N/A0.2 $0.23 6/15/20234,500 shares $1.22 thousand -65.1%N/A0.8 $0.27 5/31/202312,900 shares $4.13 thousand +1,742.9%N/A0.5 $0.32 5/15/2023700 shares $224.00 -83.7%N/A0 $0.32 4/30/20234,300 shares $1.35 thousand -4.4%N/A0.2 $0.32 4/15/20234,500 shares $1.49 thousand +50.0%N/A0.1 $0.33 3/31/20233,000 shares $907.50 +328.6%N/A0.3 $0.30 3/15/2023700 shares $245.00 No ChangeN/A0.1 $0.35 2/28/2023700 shares $266.00 -91.9%N/A0.1 $0.38 2/15/20238,600 shares $4.04 thousand +244.0%N/A0.2 $0.47 1/31/20232,500 shares $999.50 +257.1%N/A0 $0.40 1/15/2023700 shares $203.00 No ChangeN/A0 $0.29 12/30/2022700 shares $182.21 -87.7%N/A0 $0.26 12/15/20225,700 shares $1.88 thousand +714.3%N/A0.2 $0.33 11/30/2022700 shares $271.60 -86.0%N/A0 $0.39 11/15/20225,000 shares $1.50 thousand +72.4%N/A0.2 $0.30 10/31/20222,900 shares $1.31 thousand +314.3%N/A0 $0.45 10/15/2022700 shares $126.00 No ChangeN/A0 $0.18 9/30/2022700 shares $119.00 -53.3%N/A0 $0.17 9/15/20221,500 shares $450.00 No ChangeN/A0.2 $0.30 8/31/20221,500 shares $540.00 +87.5%N/A0.1 $0.36 8/15/2022800 shares $296.00 +14.3%N/A0 $0.37 7/31/2022700 shares $245.00 No ChangeN/A0 $0.35 7/15/2022700 shares $280.00 No ChangeN/A0.1 $0.40 6/30/2022700 shares $315.00 No ChangeN/A0.1 $0.45 6/15/2022700 shares $252.00 -66.7%N/A0 $0.36 5/31/20222,100 shares $840.00 -83.5%N/A0 $0.40 5/15/202212,700 shares $3.19 thousand +693.8%N/A0.2 $0.25 4/30/20221,600 shares $1.28 thousand -5.9%N/A0.2 $0.80 4/15/20221,700 shares $1.29 thousand +142.9%N/A0 $0.76 3/31/2022700 shares $700.00 -12.5%N/A0 $1.00 3/15/2022800 shares $1.09 thousand No ChangeN/A0.1 $1.36 2/28/2022800 shares $1.16 thousand -33.3%N/A0 $1.45 2/15/20221,200 shares $1.74 thousand +71.4%N/A0 $1.45 1/31/2022700 shares $980.00 -12.5%N/A0 $1.40 1/15/2022800 shares $1.15 thousand +14.3%N/A0 $1.44 12/31/2021700 shares $1.17 thousand No ChangeN/A0 $1.67 12/15/2021700 shares $1.07 thousand -50.0%N/A0 $1.53 11/30/20211,400 shares $3.01 thousand -57.6%N/A0 $2.15 11/15/20213,300 shares $4.03 thousand +230.0%N/A0.1 $1.22 10/29/20211,000 shares $1.43 thousand -23.1%N/A0.1 $1.43 10/15/20211,300 shares $2.11 thousand No ChangeN/A0.1 $1.62 9/30/20211,300 shares $2.08 thousand +44.4%N/A0.1 $1.60 9/15/2021900 shares $1.30 thousand -79.6%N/A0 $1.44 8/31/20214,400 shares $6.82 thousand +46.7%N/A0.3 $1.55The End of Elon Musk…? (Ad)The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, and he's been proven right time and time again. And now, while the media focuses on Tesla's "demise," he's uncovered an AI breakthrough that's about to make Elon's doubters eat their words yet again. According to his research, if you listen to the media and miss out on Elon's newest breakthrough, it's going to cost you the fortune of a lifetime.Click here to see why the "End of Elon" crowd is about to be wrong again. 8/13/20213,000 shares $4.65 thousand -37.5%N/A0.3 $1.55 7/30/20214,800 shares $7.20 thousand +433.3%N/A0.4 $1.50 7/15/2021900 shares $1.35 thousand No ChangeN/A0.1 $1.50 6/30/2021900 shares $1.28 thousand -70.0%N/A0.1 $1.42 6/15/20213,000 shares $4.80 thousand +150.0%N/A0.3 $1.60 5/28/20211,200 shares $1.94 thousand +33.3%N/A0.2 $1.62 5/14/2021900 shares $1.31 thousand -74.3%N/A0 $1.45 4/30/20213,500 shares $4.52 thousand +288.9%N/A0.1 $1.29 4/15/2021900 shares $1.22 thousand +28.6%N/A0.1 $1.35 3/31/2021700 shares $1.20 thousand No ChangeN/A0 $1.71 3/15/2021700 shares $1.05 thousand -50.0%N/A0 $1.50 2/26/20211,400 shares $1.97 thousand -33.3%N/A0 $1.41 2/12/20212,100 shares $3.51 thousand -12.5%N/A0 $1.67 1/29/20212,400 shares $2.93 thousand -11.1%N/A0.8 $1.22 1/15/2021700 shares $861.00 -68.2%N/A0 $1.23 12/31/2020700 shares $805.00 No ChangeN/A0 $1.15 12/15/2020700 shares $770.00 -68.2%N/A0 $1.10 11/30/20202,200 shares $2.64 thousand -31.3%N/A0.1 $1.20 11/15/20203,200 shares $2.72 thousand +3.2%N/A0.1 $0.85 10/30/20203,100 shares $2.54 thousand -75.2%N/A0.2 $0.82 10/15/202012,500 shares $9.40 thousand +468.2%N/A0.3 $0.75 9/30/20202,200 shares $2.13 thousand +144.4%N/A0.1 $0.97 9/15/2020900 shares $1.04 thousand -40.0%N/A0 $1.16 EMMA Short Interest - Frequently Asked Questions What is Emmaus Life Sciences' current short interest? Short interest is the volume of Emmaus Life Sciences shares that have been sold short but have not yet been covered or closed out. As of May 31st, traders have sold 700 shares of EMMA short. 0.00% of Emmaus Life Sciences' shares are currently sold short. Learn More on Emmaus Life Sciences' current short interest. What is a good short interest percentage for Emmaus Life Sciences? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.00% of Emmaus Life Sciences' floating shares are currently sold short. How does Emmaus Life Sciences' short interest compare to its competitors? 0.00% of Emmaus Life Sciences' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Emmaus Life Sciences: Clearmind Medicine Inc. (3.56%), InMed Pharmaceuticals Inc. (6.98%), Can-Fite BioPharma Ltd. (2.19%), Evaxion Biotech A/S (6.28%), Lixte Biotechnology Holdings, Inc. (0.49%), Sonnet BioTherapeutics Holdings, Inc. (1.53%), CERo Therapeutics Holdings, Inc. (11.78%), Synaptogenix, Inc. (0.83%), Purple Biotech Ltd (6.00%), Vivesto AB (0.00%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($64.96 billion), Invesco QQQ ($27.88 billion), iShares Russell 2000 ETF ($19.94 billion), iShares 20+ Year Treasury Bond ETF ($9.69 billion), Strategy Incorporated ($8.58 billion), SPDR S&P Biotech ETF ($5.72 billion), Invesco S&P 500 Equal Weight ETF ($5.45 billion), iShares iBoxx $ Investment Grade Corporate Bond ETF ($4.70 billion), Charter Communications, Inc. ($4.54 billion), and Industrial Select Sector SPDR Fund ($4.49 billion). View all of the most shorted stocks. What does it mean to sell short Emmaus Life Sciences stock? Short selling EMMA is an investing strategy that aims to generate trading profit from Emmaus Life Sciences as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Emmaus Life Sciences? A short squeeze for Emmaus Life Sciences occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of EMMA, which in turn drives the price of the stock up even further. How often is Emmaus Life Sciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including EMMA, twice per month. The most recent reporting period available is May, 31 2025. More Short Interest Resources from MarketBeat Related Companies Clearmind Medicine Short Squeeze InMed Pharmaceuticals Short Squeeze Can-Fite BioPharma Short Squeeze Evaxion Biotech A/S Short Squeeze Lixte Biotechnology Short Squeeze Sonnet BioTherapeutics Short Squeeze CERo Therapeutics Short Squeeze Synaptogenix Short Squeeze Purple Biotech Short Squeeze Vivesto Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:EMMA) was last updated on 6/14/2025 by MarketBeat.com Staff From Our PartnersThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredGet in stocks now - and get out on this dateGood News for Stocks 50-year Wall Street veteran, Marc Chaikin is stepping forward to share why history giv...Chaikin Analytics | Sponsored[First Look] Get in before potential 10X AI announcementsGo for 10X gains from the next big AI announcement — starting as soon as 7 days from now Former floor trade...Masters in Trading | SponsoredBig Changes Coming to Social Security?According to legendary investor Louis Navellier... This new Trump move could soon not only save Social Secu...InvestorPlace | SponsoredSHOCKING: Musk's Pentagon Secret Mission...It's about a harrowing message discovered on December 16, 2024: "美国军方暗杀名单" It's the reason President Tru...Behind the Markets | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Emmaus Life Sciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Emmaus Life Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy EMMA Stock Free EMMA Stock Alerts